Molecular Templates Revenue and Competitors
Estimated Revenue & Valuation
- Molecular Templates's estimated annual revenue is currently $24.2M per year.
- Molecular Templates's estimated revenue per employee is $216,339
- Molecular Templates's total funding is $298.2M.
- Molecular Templates's current valuation is $208.3M. (January 2022)
Employee Data
- Molecular Templates has 112 Employees.
- Molecular Templates grew their employee count by -55% last year.
Molecular Templates's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP Corporate Development | Reveal Email/Phone |
2 | SVP, Head Preclinical Development and Translational Medicine | Reveal Email/Phone |
3 | VP Intellectual Property & Chief Patent Counsel | Reveal Email/Phone |
4 | VP Process Technologies | Reveal Email/Phone |
5 | Head Talent Acquisition | Reveal Email/Phone |
6 | SVP, Translational Research and Early Development | Reveal Email/Phone |
7 | SVP and Head CMC Development | Reveal Email/Phone |
8 | VP - Head IT | Reveal Email/Phone |
9 | VP, Molecular Biology | Reveal Email/Phone |
10 | President & Chief Financial Officer | Reveal Email/Phone |
Molecular Templates Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Molecular Templates?
Molecular Templates (MTEM) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary Engineered Toxin Body (ETB) platform. MTEM's first immunotoxin, MT-3724, is in clinical development for non-Hodgkin's lymphoma. Pipeline products for additional oncology targets are being advanced toward clinical development. For more information, please visit MTEM's website at www.mtem.com.
keywords:N/A
$298.2M
Total Funding
112
Number of Employees
$24.2M
Revenue (est)
-55%
Employee Growth %
$208.3M
Valuation
N/A
Accelerator
Molecular Templates News
InvestorsObserver is giving Molecular Templates Inc (MTEM) an Analyst Rating Rank of 73, meaning MTEM is ranked higher by analysts than 73%...
Molecular Templates (NASDAQ:MTEM Get Rating) last released its quarterly earnings results on Monday, March 28th. The biotechnology company...
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics.
AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), today announced that it has ...
AUSTIN, Texas, July 20, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary targeted biologic therapeutics, engineered t ...
Other Companies in Austin
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15.7M | 112 | N/A | N/A |
#2 | $30.2M | 112 | 0% | N/A |
#3 | $28.1M | 112 | -7% | $136.9M |
#4 | $23M | 112 | 5% | N/A |
#5 | $39.5M | 112 | 42% | $6M |